Nassima Bekaddour
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Corrigendum to "Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects" [Molecular Pharmacology 107 (2025) 100055].
Journal: Molecular pharmacology
Published: September 19, 2025
Size-dependent immunomodulation by MSC secretome: soluble factors target innate pathways, components larger than 100 kDa regulate T cell proliferation.
Journal: Stem cell research & therapy
Published: July 15, 2025
Investigation of the binding mode of clobenprobit at CXCR4 and development of novel anti-inflammatory compounds with enhanced activity and minimal antagonist effects.
Journal: Molecular pharmacology
Published: February 15, 2025
The histamine analogue clobenpropit modulates IRF7 phosphorylation and interferon production by targeting CXCR4 in systemic lupus erythematosus models.
Journal: Frontiers in immunology
Published: September 03, 2024
Multivariate Screening and Automated Clustering of Macrophage Immunoreactome to Nanoparticles and Photothermal Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 06, 2024
Macrophages: Key Cellular Players in HIV Infection and Pathogenesis.
Journal: Viruses
Published: January 22, 2024
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection.
Journal: Science advances
Published: July 05, 2023
Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritis.
Journal: Frontiers in immunology
Published: March 02, 2023
Differential levels of IFNα subtypes in autoimmunity and viral infection.
Journal: Cytokine
Published: February 03, 2021
Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue.
Journal: Journal of visualized experiments : JoVE
Published: June 30, 2020
Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
Journal: Frontiers in immunology
Published: May 04, 2020
Inhibition of IFNα secretion in cells from patients with juvenile dermatomyositis under TBK1 inhibitor treatment revealed by single-molecular assay technology.
Journal: Rheumatology (Oxford, England)
Published: January 24, 2020
Last Updated: 09/26/2026